Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer

World Journal of Gastroenterology

Volumn 11, Issue 8, 2005, Pages 1210-1214

  Tan, Shi Yun ^a   Fan, Yan ^a   Luo, He Sheng ^a   Shen, Zhi Xiang ^a   Guo, Yi ^b   Zhao, Liang Jia ^c  

^a WUHAN UNIVERSITY   (China)

^b General Hospital of Wuhan Steel and Iron Group Corporation   (China)

^c Second Hospital of Jingzhou   (China)

Author keywords

Colorectal cancer; Macrophages; Mast cells; Phenotype; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CELL COUNT; CELL INFILTRATION; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MAST CELL; METASTASIS; OUTCOMES RESEARCH; PHENOTYPE; PREDICTION; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TUMOR ASSOCIATED LEUKOCYTE;

EID: 14844361270     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i8.1210     Document Type: Article

References (26)

1. Ghiara P, Boraschi D, Villa L, Scapigliati G, Taddei C, Tagliabue A. In vitro generated mast cells express natural cytotoxicity against tumour cells. Immunology 1985; 55: 317-324
2. Henderson WR, Chi EY, Jong EC, Klebanoff SJ. Mast cell-mediated tumor-cell cytotoxicity. Role of the peroxidase system. J Exp Med 1981; 153: 520-533
3. Alleva DG, Askew D, Burger CJ, Elgert KD. Fibrosarcoma induced increase in macrophage tumor necrosis factor α synthesis suppresses T cell responses. J Leukoc Biol 1993; 54: 152-160
4. Tani K, Ogushi F, Shimizu T, Sone S. Protease-induced leukocyte chemotaxis and activation: Roles in host defense and inflammation. J Med Invest 2001; 48: 133-141
5. Coussens LM, Werb Z. Inflammatory cells and cancer: Think different. J Exp Med 2001; 193: F23-1726
6. Montemurro P, Nishioka H, Dundon WG, de Bernard M, Del Giudice G, Rappuoli R, Montecucco C. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cells. Eur J Immunol 2002; 32: 671-676
7. Dimitriadou V, Koutsilieris M. Mast cell-tumor cell interactions: For or against tumour growth and metastasis? Anticancer Res 1997; 17: 1541-1549
8. He S, Walls AF. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo. Br J Pharmacol 1998; 125: 1491-1500
9. Roche WR. Mast cells and tumors. The specific enhancement of tumor proliferation in vitro. Am J Pathol 1985; 119: 57-64
10. Marks RM, Roche WR, Czerniecki M, Penny R, Nelson DS. Mast cell granules cause proliferation of human microvascular endothelial cells. Lab Invest 1986; 55: 289-294
11. Matsunaga Y, Terada T. Mast cell subpopulations in chronic inflammatory hepatobiliary diseases. Liver 2000; 20: 152-156
12. Terada T, Matsunaga Y. Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol 2000; 33: 961-966
13. Nagata M, Shijubo N, Walls AF, Ichimiya S, Abe S, Sato N. Chymase-positive mast cells in small sized adenocarcinoma of the lung. Virchows Arch 2003; 443: 565-573
14. Arizono N, Koreto O, Nakao S, Iwai Y, Kushima R, Takeoka O. Phenotypic changes in mast cells proliferating in the rat lung following infection with Nippostrongylus; brasiliensis. Virchows Arch B Cell Pathol Incl Mol Pathol 1987; 54: 1-7
15. Walls AF, Roberts JA, Godfrey RC, Church MK, Holgate ST. Histochemical heterogeneity of human mast cells: Disease-related differences in mast cell subsets recovered by bronchoalveolar lavage. Int Arch Allergy Appl Immunol 1990; 92: 233-241
16. Tomita M, Matsuzaki Y, Onitsuka T. Correlation between mast cells and survival rates in patients with pulmonary adenocarcinoma. Lung Cancer 1999; 26: 103-108
17. Aaltomaa S, Lipponen P, Papinaho S, Kosma VM. Mast cells in breast cancer. Anticancer Res 1993; 13: 785-788
18. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neural protease compositions. Proc Natl Acad Sci USA 1986; 83: 4464-4468
19. Farram E, Nelson DS. Mouse mast cells as anti-tumor effector cells. Cell Immunol 1980; 55: 294-301
20. Norrby K. Mast cells and angiogenesis. APMIS 2002; 110: 355-371
21. Qu Z, Liebler JM, Powers MR, Galey T, Ahmadi P, Huang XN, Ansel JC, Butterfield JH, Planck SR, Rosenbaum JT. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 1995; 147: 564-573
22. Meininger CJ, Zetter BR. Mast cells and angiogenesis. Semin Cancer Biol 1992; 3: 73-79
23. Grizzi F, Franceschini B, Chiriva-Internati M, Liu Y, Hermonat PL, Dioguardi N. Mast cells and human hepatocellular carcinoma. World J Gastroenterol 2003; 9: 1469-1473
24. Blair RJ, Meng H, Marchese MJ, Ren S, Schwartz LB, Tonnesen MG, Gruber BL. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 1997; 99: 2691-2700
25. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 1992; 13: 265-270
26. Hanada T, Nakagawa M, Emoto A, Nomura T, Nasu N, Nomura Y. Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol 2000; 7: 263-269